Adenocarcinoma of the esophago-gastric junction
- PMID: 17249275
- DOI: 10.1177/145749690609500409
Adenocarcinoma of the esophago-gastric junction
Abstract
Background: The border between the esophagus and stomach gives rise to many discrepancies in the current literature regarding the etiology, classification and surgical treatment of adenocarcinoma arising at the esophago-gastric junction. We have consequently used the AEG-criteria (adenocarcinoma of the esophago-gastric junction) for classification and have based the selection of the surgical approach on the anatomic topographic subclassification.
Methods: In the following we report an analysis of a large and homogeneously classified population of 1602 consecutive patients with adenocarcinoma of the esophago-gastric junction, with an emphasis on the surgical approach, the pattern of lymphatic spread, the outcome after surgical treatment and the prognostic factors. Demographic data, morphologic and histopathologic tumor characteristics, and long-term survival rates were compared among the three tumor subclassifiations.
Results: The study confirms the marked differences in sex distribution, associated specialized intestinal metaplasia in the esophagus, tumor grading, tumor growth pattern, lymphatic spread, and stage between the three tumor entities. The degree of resection and lymph node status were the dominating independent prognostic factors by multivariate analysis. The data show no significant differences of long-term survival after abdomino-thoracic esophagectomy and extended total gastrectomy in these patients.
Conclusion: The classification of adenocarcinomas of the esophago-gastric junction in three types, AEG type I, type II and type III shows marked differences between the tumor entities and is recommended for selection of a proper surgical approach. Complete tumor resection and adequate lymphadenectomy are associated with good long-term prognosis. Better surgical management and standardized procedures will improve the outcome also of patients who need to undergo more radical surgery, i.e. abdomino-thoracic esophagectomy.
Similar articles
-
Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification.J Surg Oncol. 2005 Jun 1;90(3):139-46; discussion 146. doi: 10.1002/jso.20218. J Surg Oncol. 2005. PMID: 15895452 Review.
-
Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients.Ann Surg. 2000 Sep;232(3):353-61. doi: 10.1097/00000658-200009000-00007. Ann Surg. 2000. PMID: 10973385 Free PMC article.
-
Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients.Surg Oncol Clin N Am. 2006 Oct;15(4):751-64. doi: 10.1016/j.soc.2006.07.015. Surg Oncol Clin N Am. 2006. PMID: 17030271
-
[Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Feb 25;22(2):132-142. Zhonghua Wei Chang Wai Ke Za Zhi. 2019. PMID: 30799535 Chinese.
-
Individualized surgical strategies for cancer of the esophagogastric junction.Ann Chir Gynaecol. 2000;89(3):191-8. Ann Chir Gynaecol. 2000. PMID: 11079787 Review.
Cited by
-
Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies.Gastric Cancer. 2010 Jun;13(2):63-73. doi: 10.1007/s10120-010-0555-2. Epub 2010 Jul 3. Gastric Cancer. 2010. PMID: 20602191 Review.
-
In vitro study on the role of SOX9 in trastuzumab resistance of adenocarcinoma of the esophagogastric junction.Exp Ther Med. 2018 Mar;15(3):3103-3107. doi: 10.3892/etm.2018.5744. Epub 2018 Jan 12. Exp Ther Med. 2018. PMID: 29456713 Free PMC article.
-
Comparisons of Clinical Outcomes and Prognoses in Patients With Gastroesophageal Junction Adenocarcinoma, by Transthoracic and Transabdominal Hiatal Approaches: A Teaching Hospital Retrospective Cohort Study.Medicine (Baltimore). 2015 Dec;94(50):e2277. doi: 10.1097/MD.0000000000002277. Medicine (Baltimore). 2015. PMID: 26683954 Free PMC article.
-
Effectiveness of additional antireflux surgery after resection of oesophagogastric junction cancer: protocol for a systematic review and meta-analysis.BMJ Open. 2022 Dec 29;12(12):e066061. doi: 10.1136/bmjopen-2022-066061. BMJ Open. 2022. PMID: 36581436 Free PMC article.
-
Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma-a pilot study.Curr Oncol. 2014 Jun;21(3):125-33. doi: 10.3747/co.21.1570. Curr Oncol. 2014. PMID: 24940093 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical